Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2025-12-24 @ 11:05 PM
NCT ID:
NCT03712969
Eligibility Criteria:
Inclusion Criteria:
* Age 18 or older;
* Pathological diagnosis of patients with stage II, III A primary NSCLC;
* R0 resection has been accepted;
* Received adjuvant chemotherapy or adjuvant chemotherapy for the first time after surgery;
* Informed consent has been signed.
Exclusion Criteria:
* Incorporation of other malignant tumors (such as leukemia, liver cancer, etc.);
* Patients with unclear pathological types;
* Patients with unclear pathological staging;
* Preserved Shenlingcao Oral Liquid before R0 resection surgery;
* Received immunotherapy or targeted therapy before R0 resection surgery;
* Radiotherapy and chemotherapy before R0 resection surgery.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03712969
Study Brief:
Protocol Section:
NCT03712969